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BASICS 
DESCRIPTION 
• From the Latin, hirsutus = hairy 
• Symptom associated with male pattern of 
pigmented terminal hair growth 
Locations are assessed for research purposes in 
Ferriman-Gallwey score. 
• Often associated with acne, irregular menstrual 
periods, galactorrhea, dark velvety patches of skin, 
central obesity, infertility 
Pediatric Considerations 
Infancy to late childhood ( < 10 years of age): 
Associated with Cornelia de Lange syndrome, FAS, 
CAH, adrenocortical tumors, or drug-induced 
., Adolescence: Associated with PCOS, late-onset 
CAH, HAIR-AN syndrome, steroid use, depression, 
pregnancy, or drug-induced 
Adulthood: Associated with PCOS, HAIR-AN 
syndrome, hyperprolactinemia, ovarian tumor, 
menopause, depression, or drug-induced 
EPIDEMIOLOGY 
5- 1 0% of women, of which 20% have idiopathic 
hirsutism 
RISK FACTORS 
Ethnicity (Mediterranean, Middle Eastern, South 
Asian) 
• Family history 
• Infertility 
• Obesity 
Genetics 
Can be familial or multifactorial 
' Seen with: 
- Polymorphism of 5 a-reductase (SRD5A 1 and 
SRD5A2) isomers 
- CYP21 gene mutation 
- NIPBL mutation associated with Cornelia de 
Lange syndrome 
PATHOPHYSIOLOGY 
• Caused by increased: 
- Levels of androgen secretion (DHEA, DHEAS, 
androstenedione and testosterone) 
- Peripheral conversion of testosterone to potent 
DHT 
-Sensitivi ty of hair follicles to androgens regulated 
by 5 a-reductase, which transforms testosterone 
or androstenedione to DHT 
• Caused by decreased: 
- SHBG concentration with resultant increased free 
androgen 
ASSOCIATED CONDITIONS 
'" Idiopathic hirsutism 
• PCOS 
• HAIR-AN syndrome 
• CAH 
• Cushing disease 
• Hyperthecosis 
• Hypothyroidism 
• Hyperprolactinemia 
• Adrenocortical tumors 
• Ovarian tumors 
• Cornelia de Lange syndrome 
• Fetal alcohol syndrome 
• Drugs: Corticostero ids, anabolic steroids, phenytoin, 
valproate, danazol, diazoxide, minoxidil 
• Pregnancy 
• Stress 
• Male pseudohermaphroditism 
• Depression 
DIAGNOSIS 
SIGNS AND SYMPTOMS 
• Based on the Ferriman-Gallwey score of ha ir growth 
level on 9 different locations of the body: 
-Upper lip, chin, chest, upper back, lower back, 
upper abdomen, lower abdomen, upper arms, and 
thighs 
- Hair growth is rated from 0- 4, where 0 is virtually 
no hair at all, and 4 is completely covered with 
hair. The maximum score is 36. Commonly used 
research scale in US 
-Normal: < 8 
o Light hirsutism: 8-16 
o Moderate hirsutism: 17-25 
o Severe hirsutism: >26 
• The scale may vary for different ethnic groups with 
different levels of expected hair growth. 
History 
' Age of onset 
• Duration 
• Location 
• Rate of progression 
• Skin changes 
• Associated symptoms of virilization 
' Medication use 
• Ethnic background 
• Medical history 
• Puberty/Menstrual history 
• Family history of females with hirsutism, males with 
early balding 
• Psychosocia l history/stress, depression 
Review of Systems 
Other associated signs and symptoms: 
• Acne 
• Irregular menstrual periods ,'<'' 
• Dark velvety patches of skin1acanthosis nigricans) 
• Breast disch~rge 
• Central obesity 
• Deepening of the voice 
• Increased muscle mass 
• Infertili ty 
Physical Exam 
• Vitals: Increased BMI, high BP, waist circumference 
> 30 inches 
• General: Central obes ity, BMI, dysmorphism, 
deepening of voice, male habitus 
• Skin: Acne, male pattern hair, seborrhea 
• HEENT: Tonsillar en largement, thyromegaly, 
acanthosis nigricans, cervical fat pad, temporal 
balding 
• Chest: Breast tenderness, galactorrhea, truncal 
obesity, buffalo hump 
• Abdomen: Striae, tenderness 
• GU: Clitoromegaly, ovarian mass 
TESTS 
Ferriman-Gallwey scoring for research purposes 
Labs 
Testing as clinically appropriate for: 
• DHEA-S 
• Total testosterone 
• Free testosterone 
• Fasting Insulin and glucose 
• IGF-1 
• TSH 
• Free T4 
• 17 OH progesterone 
• Prolactin 
• LH 
• FSH 
• ACTH 
• Cortisol 
• 24-hour urine cortisol 
Imaging 
• Pelvic ultrasound if ovarian mass suspected 
• CT abdomen and pelvis if adrenal mass suspected 
• MRI head if pituitary abnormality suspected 
DIFFERENTIAL DIAGNOSIS 
• Hypertrichosis: Excessive androgen-independent fine 
and soft total body hair growth in both men and 
women 
• Idiopathic hirsutism 
increase rate of hair growth. 
using aminolevulinic 
growth. 
(Foenicu/um vulgare) 
inhibits growth. 
roots have lignans 
SHBG. 
MEDICATION (DRUGS) 
Aimed at primary cause of hirsutism: 
OCP reduces circulating androgen levels through 
suppression of circulating LH, stimulation of SHBG 
levels with resultant decreases in free androgens, 
and reduction of Sa-reductase activity 
Clomiphene induces ovulation 
Metformin promotes ovulation and reduces insulin 
resistance of peripheral tissue. 
Gonadotropins: Leuprolide 
Cyproterone competes with DHT for binding to the 
androgen receptor. 
Spironolactone competes with DHT for binding to 
the androgen receptor. 
Flutamide is a pure androgen receptor blocker. 
Ketoconazole reduces levels of concentration of 
circulating androgens. 
Finasteride inhibits activity of Sa-reductase, 
SURGERY 
0 Hair removal with intense pulsed light irradiator 
system (IPL) or normal-mode ruby laser for 
idiopathic or familial hirsutism 
Surgery can be aimed at underlying pathology: 
-Adrenal/Ovarian tumor resection 
-Oophorectomy for androgen-producing ovarian 
tumor 
-Ovarian wedge resection/ovarian drilling in PCOS 
FOLLOW-UP 
;/ 
Depends on cause or associated condition 
DISPOSITION 
Issues for Referral 
Endocrinology or gynecology or genetics or surgery 
for hormonal or syndromic or tumor etiology 
Dermatology or cosmetology for idiopathic or 
familial hirsutism only 
PROGNOSIS 
Dependent on cause and intervention or therapy 
PATIENT MONITORING 
Endocrinology or gynecology or genetics or surgery 
for hormonal or syndromic or tumor etiology 
Dermatology or cosmetology for idiopathic or 
familial hirsutism only 
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MISCELLANEOUS 
Virilization indicates more severe androgen effect 
including breast atrophy, clitoromegaly, temporal 
balding 
CLINICAL PEARLS 
Hirsutism without menstrual irregularities or weight 
gain is most likely idiopathic or familial. 
Adolescents with hirsutism and early-onset, severe, 
and refractory acne are likely to have PCOS; OCPs 
can benefit self-esteem and prevent scarring from 
acne. 
Hirsutism can be the only clinical presentation of 
depression or stress in adolescents; warrants 
psychosocial workup. 
ABBREVIATIONS 
ACTH-Adrenocorticotropic hormone 
CAH-Congenital adrenal hyperplasia 
DHEAIDHEAS-Dehydroepiandrosterone-DHEAS 
sulfate 
DHT-Sa-dihydrotestosterone 
FAS-Fetal alcohol syndrome 
FSH-Follicular stimulating hormone 
HEENT-Head, eyes, ears, nose, throat exam 
IGF-1-Insulin-like growth factor · 
LH-Luteinizing hormone 
OCP-Oral contraceptive pill 
PCOS-Polycystic ovarian syndrome 
SHBG-Sex hormone binding globulin 
TSH-Thyroid stimulating hormone 
704.1 Hirsutism 
PATIENT TEACHING 
o Diagnosis of idiopathic hirsutism or familial hirsutism 
should be considered after a thorough workup for 
all other causes such as hormonal, oncologic, and 
syndromic agents have been ruled out. 
Current medical therapies have their pros and cons. 
No drug is yet FDA approved. Cosmetic remediation 
or counseling and education may also be helpful. 
PREVENTION 
Exercise for weight control and stress reduction may 
improve PCOS. 
Careful use of medication such as steroids, 
antiepileptics, vasodilators with awareness of 
hirsutism as side effect 
